Discover AutoCT at SCT 2025 – The Future of Clinical-Phase Regulatory Submissions

Weave is heading to the Society for Clinical Trials (SCT) 46th Annual Meeting, where we’ll unveil AutoCT, our latest AI-powered platform designed to streamline clinical-phase regulatory submissions.

Location: Vancouver, British Columbia, Canada
Booth: #100
Dates: May 18–21, 2025

Regulatory teams often work across fragmented tools and manual processes, slowing down submission timelines. Weave provides regulatory teams with one unified home for submission preparation through our AI-powered workbench. Now, with AutoCT, clinical-phase filings can be drafted, refined, and reviewed faster than ever, ensuring consistency and eliminating redundant work across:

• Clinical study reports
• Protocols and amendments
• Safety reports and annual reports
• Investigator’s Brochures (IBs)

Why Visit Booth #100?

• Be Among the First to Experience AutoCT – Get an exclusive look at how AI is reshaping clinical-phase submissions.
• Streamline Your Regulatory Workflows – Learn how automation enhances accuracy, efficiency, and compliance across clinical documentation.
• See the Weave Workbench in Action – Discover how Weave gives regulatory teams one home to manage submissions from IND to NDA.
• Meet Our Experts – Discuss your regulatory challenges and explore tailored solutions with the Weave team.

Join us at SCT 2025 and see how AutoCT is redefining the regulatory landscape for clinical trials.

For more information, visit the SCT 2025 website or contact us at info@weave.bio.